États-Unis · Agences & temps réel · PR Newswire

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Publié par PR Newswire · États-Unis il y a 1 h

BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing…

Lire l'article complet sur PR Newswire Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.prnewswire.com)

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

À lire aussi

What to consider if a company that made AI-related job cuts wants you back

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Partager

À lire aussi

What to consider if a company that made AI-related job cuts wants you back

Takeaways from the Inaugural Dow Jones Energy Forum

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows